Here, we identify novel targets for functional and potential future therapeutic intervention studies, identifying differentially methylated and expressed genes SKI, GTF2H4, and TNXB that regulate disease pathways implicated in AMD. This evidence concerns the gene TNXB and age-related macular degeneration.